BR9713294A - "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano" - Google Patents
"anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano"Info
- Publication number
- BR9713294A BR9713294A BR9713294-2A BR9713294A BR9713294A BR 9713294 A BR9713294 A BR 9713294A BR 9713294 A BR9713294 A BR 9713294A BR 9713294 A BR9713294 A BR 9713294A
- Authority
- BR
- Brazil
- Prior art keywords
- antibodies against
- human parathyroid
- parathyroid hormone
- protein related
- against protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Patente de Invenção: <B>''ANTICORPOS CONTRA PROTEìNA RELACIONADA A HORMÈNIO DE PARATIRóIDE HUMANO"<D>. São divulgados um anticorpo contra uma proteína relacionada a hormónio de paratiróide humano, um DNA que codifica para o anticorpo, um vetor recombinante que contém o DNA, um transformante transformado com o vetor recombinante, um processo para preparação do anticorpo e usos do anticorpo.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25519696 | 1996-09-26 | ||
JP21416897 | 1997-07-24 | ||
PCT/JP1997/003382 WO1998013388A1 (fr) | 1996-09-26 | 1997-09-24 | Anticorps contre les peptides lies a la parathormone humaine |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9713294A true BR9713294A (pt) | 2000-10-17 |
Family
ID=26520176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9713294-2A BR9713294A (pt) | 1996-09-26 | 1997-09-24 | "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano" |
Country Status (17)
Country | Link |
---|---|
US (3) | US6903194B1 (pt) |
EP (1) | EP0962467A4 (pt) |
KR (1) | KR100847441B1 (pt) |
CN (1) | CN100335501C (pt) |
AU (1) | AU744146B2 (pt) |
BR (1) | BR9713294A (pt) |
CA (1) | CA2266332C (pt) |
CZ (1) | CZ106299A3 (pt) |
HK (1) | HK1096974A1 (pt) |
HU (1) | HUP9904177A3 (pt) |
IL (1) | IL129164A (pt) |
NO (1) | NO991449L (pt) |
RU (1) | RU2198220C2 (pt) |
SK (1) | SK40599A3 (pt) |
TR (1) | TR199900666T2 (pt) |
TW (1) | TW509697B (pt) |
WO (1) | WO1998013388A1 (pt) |
Families Citing this family (101)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU744146B2 (en) | 1996-09-26 | 2002-02-14 | Chugai Seiyaku Kabushiki Kaisha | Antibody against human parathormone related peptides |
TR199902800T2 (xx) | 1997-05-15 | 2000-04-21 | Chugai Seiyaku Kabushiki Kaisha | Ka�eksiyi tedavi edici madde. |
BR9912223A (pt) * | 1998-06-26 | 2001-04-24 | Chugai Pharmaceutical Co Ltd | Agente terapêutico para crise hipercalcêmica |
DE60021373T2 (de) * | 1999-05-10 | 2006-04-27 | Chugai Seiyaku K.K. | Verfahren der zellkultivierung |
TWI255718B (en) | 1999-07-02 | 2006-06-01 | Chugai Pharmaceutical Co Ltd | Ameliorative agent for low vasopressin concentration |
AU5708500A (en) * | 1999-07-02 | 2001-01-22 | Chugai Seiyaku Kabushiki Kaisha | Remedies for diseases caused by pth or pthrp |
EP1195164A4 (en) * | 1999-07-06 | 2005-09-28 | Chugai Pharmaceutical Co Ltd | MEDICINAL PRODUCTS FOR THERAPY-BASED HYPERCALCEMENTS |
BR0014667A (pt) | 1999-10-01 | 2002-07-02 | Chugai Pharmaceutical Co Ltd | Prevenção e tratamento de doenças relacionadas à coagulação sanguìnea |
EP1254666A4 (en) * | 1999-12-28 | 2004-12-22 | Chugai Pharmaceutical Co Ltd | STABLE ANTIBODY COMPOSITIONS AND INJECTION FORMULATIONS |
US20030049211A1 (en) * | 2000-01-25 | 2003-03-13 | Atsuhiko Kato | Remedies and preventives for dental diseases |
WO2001064249A1 (en) * | 2000-02-28 | 2001-09-07 | Chugai Seiyaku Kabushiki Kaisha | Tissue decomposition inhibitor |
EP1987842A1 (en) * | 2000-04-28 | 2008-11-05 | Chugai Seiyaku Kabushiki Kaisha | Cell proliferation inhibitor |
US8632778B2 (en) | 2000-08-11 | 2014-01-21 | Chugai Seiyaku Kabushiki Kaisha | Stabilized anti-interleukin-6 antibody-containing preparations |
US20040067231A1 (en) * | 2000-08-16 | 2004-04-08 | Hideki Yoshikawa | Agents for ameliorating symtoms caused by joint diseases |
US20060063152A1 (en) | 2000-12-22 | 2006-03-23 | Osamu Ohara | Novel gene and protein encoded by the gene |
EP1380589A4 (en) * | 2001-03-09 | 2004-09-01 | Chugai Pharmaceutical Co Ltd | PROTEIN CLEANING METHOD |
US20040213788A1 (en) * | 2001-05-18 | 2004-10-28 | Sweet Raymond W. | Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
WO2003040966A2 (en) | 2001-11-02 | 2003-05-15 | Siemens Medical Solutions Usa, Inc. | Patient data mining for automated compliance |
US8949082B2 (en) | 2001-11-02 | 2015-02-03 | Siemens Medical Solutions Usa, Inc. | Healthcare information technology system for predicting or preventing readmissions |
US7457731B2 (en) | 2001-12-14 | 2008-11-25 | Siemens Medical Solutions Usa, Inc. | Early detection of disease outbreak using electronic patient data to reduce public health threat from bio-terrorism |
DK1475101T3 (da) | 2002-02-14 | 2011-01-10 | Chugai Pharmaceutical Co Ltd | Antistof-holdige farmaceutiske opløsninger |
FR2841788B1 (fr) * | 2002-07-05 | 2006-01-27 | Univ Pasteur | Utilisation d'antagonistes de la pthrp pour traiter le carcinome a cellules renales |
AU2003257536A1 (en) | 2002-08-27 | 2004-03-19 | Chugai Seiyaku Kabushiki Kaisha | Method of stabilizing protein solution preparation |
WO2004022595A1 (ja) | 2002-09-04 | 2004-03-18 | Chugai Seiyaku Kabushiki Kaisha | MRL/lprマウスを用いた抗体の作製 |
US7680086B2 (en) * | 2002-09-09 | 2010-03-16 | Siemens Canada Limited | Wireless local area network with clients having extended freedom of movement |
SI1561756T1 (sl) | 2002-09-11 | 2016-02-29 | Chugai Seiyaku Kabushiki Kaisha | Postopek čiščenja proteinov |
WO2004043405A2 (en) * | 2002-11-12 | 2004-05-27 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
US7794711B2 (en) * | 2002-11-18 | 2010-09-14 | Chugai Seiyaku Kabushiki Kaisha | Agent for treating chondroma and chondrosarcoma |
US20080153104A1 (en) | 2003-08-08 | 2008-06-26 | Hiroyuki Aburantai | Gene Overexpressed in Cancer |
EP2468769A1 (en) * | 2004-04-21 | 2012-06-27 | The Brigham and Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
CN111925445A (zh) | 2004-07-09 | 2020-11-13 | 中外制药株式会社 | 抗-磷脂酰肌醇蛋白聚糖3抗体 |
JP5620626B2 (ja) | 2005-03-31 | 2014-11-05 | 中外製薬株式会社 | 会合制御によるポリペプチド製造方法 |
US20080275731A1 (en) * | 2005-05-18 | 2008-11-06 | Rao R Bharat | Patient data mining improvements |
JP5224580B2 (ja) | 2005-06-10 | 2013-07-03 | 中外製薬株式会社 | sc(Fv)2部位特異的変異体 |
AU2006256041B2 (en) * | 2005-06-10 | 2012-03-29 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
US9241994B2 (en) * | 2005-06-10 | 2016-01-26 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical compositions containing sc(Fv)2 |
JP2008546716A (ja) * | 2005-06-17 | 2008-12-25 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | 抗GFRα3抗体 |
KR101323563B1 (ko) | 2005-10-18 | 2013-10-29 | 니토 보세키 가부시기가이샤 | 항체를 생산하는 트랜스제닉 누에와 그의 제조방법 |
DOP2006000277A (es) | 2005-12-12 | 2007-08-31 | Bayer Pharmaceuticals Corp | Anticuerpos anti mn y métodos para su utilización |
WO2007074880A1 (ja) | 2005-12-28 | 2007-07-05 | Chugai Seiyaku Kabushiki Kaisha | 抗体含有安定化製剤 |
EP4342995A3 (en) | 2006-03-31 | 2024-05-15 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
US9670269B2 (en) | 2006-03-31 | 2017-06-06 | Chugai Seiyaku Kabushiki Kaisha | Methods of modifying antibodies for purification of bispecific antibodies |
EP2011513B1 (en) | 2006-04-25 | 2016-10-19 | The University of Tokyo | Therapeutic agents for alzheimer's disease and cancer |
KR20090021217A (ko) | 2006-06-14 | 2009-02-27 | 추가이 세이야쿠 가부시키가이샤 | 조혈 줄기세포 증가 촉진제 |
US9023993B2 (en) | 2006-10-20 | 2015-05-05 | Chugai Seiyaku Kabushiki Kaisha | Anti-cancer agent comprising anti-HB-EGF antibody as active ingredient |
WO2008047925A1 (fr) | 2006-10-20 | 2008-04-24 | Forerunner Pharma Research Co., Ltd. | Composition pharmaceutique comprenant un anticorps anti-hb-egf comme ingrédient actif |
ATE504647T1 (de) | 2007-01-30 | 2011-04-15 | Forerunner Pharma Res Co Ltd | Chimärer fc gamma rezeptor und verfahren zur bestimmung von adcc-aktivität unter verwendung des rezeptors |
US8501929B2 (en) * | 2007-08-17 | 2013-08-06 | Biochrom Pharma Inc. | PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
US7897139B2 (en) * | 2007-08-17 | 2011-03-01 | Biochrom Pharma, Inc. | PTHrP, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
AR066172A1 (es) | 2007-09-28 | 2009-07-29 | Chugai Pharmaceutical Co Ltd | Metodo para la preparacion de un anticuerpo antiglipicano 3 con modulada cinetica plasmatica mediante variacion de la semivida plasmatica. |
KR101840994B1 (ko) | 2007-12-05 | 2018-03-21 | 추가이 세이야쿠 가부시키가이샤 | 항nr10 항체 및 그의 이용 |
PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
EP3056513A1 (en) | 2008-04-11 | 2016-08-17 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
KR20110031393A (ko) | 2008-07-21 | 2011-03-25 | 더 브리검 앤드 우먼즈 하스피털, 인크. | 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물 |
WO2010055950A1 (ja) | 2008-11-17 | 2010-05-20 | 財団法人ヒューマンサイエンス振興財団 | 癌間質の構成因子に対して特異的結合能を有する物質と抗腫瘍性化合物との複合体による新規の癌ターゲティング治療 |
JP2010210772A (ja) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
US9340615B2 (en) | 2009-05-15 | 2016-05-17 | Chugai Seiyaku Kabushiki Kaisha | Anti-AXL antibody |
WO2011021381A1 (ja) | 2009-08-17 | 2011-02-24 | 株式会社未来創薬研究所 | 抗hb-egf抗体を有効成分として含む医薬組成物 |
US8751495B2 (en) * | 2009-09-29 | 2014-06-10 | Siemens Medical Solutions Usa, Inc. | Automated patient/document identification and categorization for medical data |
TWI505838B (zh) | 2010-01-20 | 2015-11-01 | Chugai Pharmaceutical Co Ltd | Stabilized antibody solution containing |
US20110184761A1 (en) * | 2010-01-25 | 2011-07-28 | Siemens Medical Solutions Usa, Inc. | Method and Apparatus for Estimating Patient Populations |
TWI667346B (zh) | 2010-03-30 | 2019-08-01 | 中外製藥股份有限公司 | 促進抗原消失之具有經修飾的FcRn親和力之抗體 |
US10943676B2 (en) | 2010-06-08 | 2021-03-09 | Cerner Innovation, Inc. | Healthcare information technology system for predicting or preventing readmissions |
ES2899186T3 (es) | 2010-12-31 | 2022-03-10 | Bioatla Inc | Humanización rápida de anticuerpos |
EP2663333B8 (en) | 2011-01-10 | 2020-06-17 | The Regents Of The University Of Michigan | Stem cell factor inhibitor |
US20150018408A1 (en) * | 2013-07-10 | 2015-01-15 | The Regents Of The University Of Michigan | Therapeutic antibodies and uses thereof |
WO2013012022A1 (ja) | 2011-07-19 | 2013-01-24 | 中外製薬株式会社 | アルギニンアミドまたはその類似化合物を含む安定なタンパク質含有製剤 |
MY182178A (en) | 2011-09-01 | 2021-01-18 | Chugai Pharmaceutical Co Ltd | Method for preparing a composition comprising highly concentrated antibodies by ultrafiltration |
JP6077997B2 (ja) | 2011-09-07 | 2017-02-08 | 中外製薬株式会社 | 癌幹細胞の分離 |
JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
TW201817744A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
WO2013062083A1 (ja) | 2011-10-28 | 2013-05-02 | ファーマロジカルズ・リサーチ プライベート リミテッド | 癌幹細胞特異的分子 |
WO2013065708A1 (ja) | 2011-10-31 | 2013-05-10 | 中外製薬株式会社 | 重鎖と軽鎖の会合が制御された抗原結合分子 |
WO2013161814A1 (ja) | 2012-04-23 | 2013-10-31 | ジーンフロンティア株式会社 | 抗ヒトcd69抗体、及びその医薬用途 |
EP2902489B9 (en) | 2012-09-27 | 2018-02-07 | Chugai Seiyaku Kabushiki Kaisha | Fgfr3 fusion gene and pharmaceutical drug targeting same |
US10565315B2 (en) | 2012-09-28 | 2020-02-18 | Cerner Innovation, Inc. | Automated mapping of service codes in healthcare systems |
US10318635B2 (en) | 2012-09-28 | 2019-06-11 | Cerner Innovation, Inc. | Automated mapping of service codes in healthcare systems |
US10403391B2 (en) | 2012-09-28 | 2019-09-03 | Cerner Health Services, Inc. | Automated mapping of service codes in healthcare systems |
EP2918678B1 (en) | 2012-11-09 | 2019-01-30 | GeneFrontier Corporation | Anti-adam28 antibody for treating cancer |
US10540448B2 (en) | 2013-07-15 | 2020-01-21 | Cerner Innovation, Inc. | Gap in care determination using a generic repository for healthcare |
JP6534615B2 (ja) | 2013-09-27 | 2019-06-26 | 中外製薬株式会社 | ポリペプチド異種多量体の製造方法 |
EP3057992B1 (en) | 2013-10-15 | 2024-04-17 | GeneFrontier Corporation | Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases |
EP3581179A1 (en) | 2013-12-27 | 2019-12-18 | Chugai Seiyaku Kabushiki Kaisha | Fgfr gatekeeper mutant gene and drug targeting same |
CN106029682B (zh) | 2013-12-27 | 2021-04-13 | 中外制药株式会社 | 等电点低的抗体的纯化方法 |
US10703798B2 (en) | 2014-03-31 | 2020-07-07 | Debiopharm International Sa | Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL) |
JP6858559B2 (ja) | 2014-08-20 | 2021-04-14 | 中外製薬株式会社 | 蛋白質溶液の粘度測定方法 |
MA40764A (fr) | 2014-09-26 | 2017-08-01 | Chugai Pharmaceutical Co Ltd | Agent thérapeutique induisant une cytotoxicité |
EP3816179A3 (en) | 2015-02-05 | 2021-08-04 | Chugai Seiyaku Kabushiki Kaisha | Fc region variant comprising a modified fcrn-binding domain |
TW202342532A (zh) | 2015-09-18 | 2023-11-01 | 日商中外製藥股份有限公司 | Il-8結合抗體及其用途 |
KR20180069839A (ko) | 2015-10-08 | 2018-06-25 | 자임워크스 인코포레이티드 | 카파 및 람다 경사슬을 포함하는 항원-결합 폴리펩티드 구조체 및 이의 용도 |
EP3694883A1 (en) | 2017-10-12 | 2020-08-19 | Keio University | Anti aqp3 monoclonal antibody specifically binding to extracellular domain of aquaporin 3 (aqp3) and use thereof |
KR20210010996A (ko) | 2018-05-21 | 2021-01-29 | 추가이 세이야쿠 가부시키가이샤 | 유리 용기에 봉입된 동결건조 제제 |
CN115649558A (zh) | 2018-05-28 | 2023-01-31 | 中外制药株式会社 | 填充喷嘴 |
CA3102060A1 (en) | 2018-05-31 | 2019-12-05 | Shionogi & Co., Ltd. | Nav1.7 monoclonal antibody |
JP6894086B2 (ja) | 2018-12-27 | 2021-06-23 | 塩野義製薬株式会社 | 新規抗ccr8抗体 |
WO2020213084A1 (en) | 2019-04-17 | 2020-10-22 | Keio University | Anti aqp3 monoclonal antibody specifically binding to extracellular domain of aquaporin 3 (aqp3) and use thereof |
WO2022004760A1 (ja) | 2020-06-30 | 2022-01-06 | 塩野義製薬株式会社 | 抗ccr8抗体と化学療法剤の併用 |
TW202323810A (zh) | 2021-10-08 | 2023-06-16 | 日商中外製藥股份有限公司 | 預填充式注射器製劑的調製方法 |
IL311683A (en) | 2021-11-01 | 2024-05-01 | Shionogi & Co | A new Nav1.7 monoclonal antibody |
CN115109161B (zh) * | 2022-06-28 | 2023-08-11 | 广东赛尔生物科技有限公司 | 含有间充质干细胞的减肥药物组合物 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) * | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US5618920A (en) * | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
US5001223A (en) | 1987-05-26 | 1991-03-19 | Merck & Co., Inc. | Parathyroid hormone antagonists with enhanced metabolic properties |
US4771124A (en) | 1987-05-26 | 1988-09-13 | Merck & Co., Inc. | Parathyroid hormone antagonists with simplified synthetic methodology |
EP0293130A3 (en) | 1987-05-26 | 1990-06-13 | Merck & Co. Inc. | Dimers of parathyroid hormone antagonists |
EP0293158A3 (en) | 1987-05-26 | 1990-05-09 | Merck & Co. Inc. | Parathyroid hormone antagonists |
EP0417193B1 (en) | 1988-05-27 | 1993-08-04 | Centocor, Inc. | Freeze-dried formulation for antibody products |
EP0417191B1 (en) | 1988-05-27 | 1993-03-10 | Centocor, Inc. | Formulation for antibody reagents |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5217896A (en) | 1988-12-30 | 1993-06-08 | Oncogene Science, Inc. | Monoclonal antibodies recognizing parathyroid hormone-like protein |
JPH02207099A (ja) | 1989-02-07 | 1990-08-16 | Tonen Corp | PTHrP関連ペプチド、その製造法及び用途 |
CA2035179C (en) | 1990-01-31 | 2001-08-14 | Gerald S. Brenner | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
GB9009548D0 (en) | 1990-04-27 | 1990-06-20 | Celltech Ltd | Chimeric antibody and method |
JPH04228089A (ja) | 1990-05-15 | 1992-08-18 | Kanegafuchi Chem Ind Co Ltd | 高カルシウム血症治療・予防剤 |
EP0539491A1 (en) | 1990-07-13 | 1993-05-05 | The Regents Of The University Of California | PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
DE4034612A1 (de) * | 1990-10-31 | 1992-05-07 | Huels Chemische Werke Ag | Verfahren zur herstellung von methacryloxy- oder acryloxygruppen enthaltenden organosilanen |
CA2107569C (en) | 1991-04-05 | 2011-08-02 | Gino V. Segre | Parathyroid hormone receptor and dna encoding same |
US5795965A (en) | 1991-04-25 | 1998-08-18 | Chugai Seiyaku Kabushiki Kaisha | Reshaped human to human interleukin-6 receptor |
DE4137744C2 (de) * | 1991-11-15 | 1996-10-31 | Kuesters Eduard Maschf | Verfahren zum Herstellen eines Schichtwerkstoffs unter Wiederverwendung von Kunststoffabfällen und eigensteifer, Kunstsoffabfälle enthaltender Schichtwerkstoff |
AU3095892A (en) * | 1991-12-20 | 1993-07-28 | Protein Design Labs, Inc. | Human type antibody reactive with GPIIb/IIIa |
US5993617A (en) | 1991-12-26 | 1999-11-30 | Asahi Glass Company Ltd. | Functional product |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
US5849695A (en) | 1993-01-13 | 1998-12-15 | The Regents Of The University Of California | Parathyroid hormone analogues useful for treatment of osteoporosis and disorders of calcium meatabolism in mammals |
JP3504697B2 (ja) | 1993-09-30 | 2004-03-08 | 株式会社先端生命科学研究所 | PTHrPアンタゴニスト活性を有するポリペプチド及びそれを含むカルシウム代謝治療薬 |
JPH07316195A (ja) | 1994-05-25 | 1995-12-05 | Nippon Kayaku Co Ltd | 新規なPTHrP関連ペプチド及びその用途 |
CO4410206A1 (es) | 1994-07-28 | 1997-01-09 | Sandoz Ag | DERIVADOS DE PTH o PTHrP, SU PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN |
US5626845A (en) | 1995-01-23 | 1997-05-06 | Xenotech Incorporated | Method to ameliorate osteolysis and metastasis |
US5993817A (en) | 1995-01-23 | 1999-11-30 | Xenotech | Method to ameliorate osteolysis and metastasis |
JP4231106B2 (ja) * | 1995-01-23 | 2009-02-25 | ゼノテック インコーポレイティッド | 骨溶解および転移を改善する方法 |
DK0811383T3 (da) | 1995-02-20 | 2007-06-25 | Yukio Kato | Lægemidler til arthrosis deformans og inflammatoriske ledsygdomme |
CA2214341A1 (en) | 1995-03-01 | 1996-09-06 | Creative Biomolecules, Inc. | Morphogen-induced dentine regeneration |
EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
US5660826A (en) | 1995-06-06 | 1997-08-26 | The Regents Of The University Of California | Therapeutic sepsis treatment using antagonists to PTHrP |
JP2000513201A (ja) | 1995-07-20 | 2000-10-10 | アイ・シー・エヌ・フアーマシユーテイカルズ | 上皮小体ホルモン様たんぱく質に関連する化合物および方法 |
ATE219374T1 (de) | 1996-02-01 | 2002-07-15 | Chugai Pharmaceutical Co Ltd | Medikamente für die behandlung oder vorbeugung von thrombocytopenie |
CA2265915C (en) | 1996-09-10 | 2012-11-20 | Theodor-Kocher Institute | Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use |
AU744146B2 (en) | 1996-09-26 | 2002-02-14 | Chugai Seiyaku Kabushiki Kaisha | Antibody against human parathormone related peptides |
JP4228089B2 (ja) | 1997-03-11 | 2009-02-25 | 株式会社ニコン | 過電流検知機構およびそれを用いた電子閃光装置 |
TR199902800T2 (xx) | 1997-05-15 | 2000-04-21 | Chugai Seiyaku Kabushiki Kaisha | Ka�eksiyi tedavi edici madde. |
JP4372240B2 (ja) | 1997-05-15 | 2009-11-25 | 中外製薬株式会社 | 悪液質治療剤 |
JP3791863B2 (ja) | 1997-07-04 | 2006-06-28 | 株式会社フジタ | 鉄筋コンクリート系建物の制震構造 |
JP4414494B2 (ja) | 1998-02-03 | 2010-02-10 | 旭化成ファーマ株式会社 | 白血球減少症の予防剤および治療剤 |
HUP0300891A2 (hu) | 1998-05-05 | 2003-07-28 | Beth Israel Deaconess Medical Center, Inc. | PTH2 receptor szelektív vegyületek és alkalmazásuk gyógyszerkészítmények előállÍtására |
JP2000080100A (ja) | 1998-06-17 | 2000-03-21 | Japan Tobacco Inc | 副甲状腺ホルモン関連タンパクに対するヒトモノクローナル抗体 |
BR9912223A (pt) | 1998-06-26 | 2001-04-24 | Chugai Pharmaceutical Co Ltd | Agente terapêutico para crise hipercalcêmica |
-
1997
- 1997-09-24 AU AU43972/97A patent/AU744146B2/en not_active Ceased
- 1997-09-24 IL IL129164A patent/IL129164A/en not_active IP Right Cessation
- 1997-09-24 WO PCT/JP1997/003382 patent/WO1998013388A1/ja active IP Right Grant
- 1997-09-24 BR BR9713294-2A patent/BR9713294A/pt not_active Application Discontinuation
- 1997-09-24 CZ CZ991062A patent/CZ106299A3/cs unknown
- 1997-09-24 HU HU9904177A patent/HUP9904177A3/hu unknown
- 1997-09-24 RU RU99108713/13A patent/RU2198220C2/ru not_active IP Right Cessation
- 1997-09-24 SK SK405-99A patent/SK40599A3/sk unknown
- 1997-09-24 TR TR1999/00666T patent/TR199900666T2/xx unknown
- 1997-09-24 CA CA2266332A patent/CA2266332C/en not_active Expired - Fee Related
- 1997-09-24 US US09/269,332 patent/US6903194B1/en not_active Expired - Fee Related
- 1997-09-24 CN CNB971997225A patent/CN100335501C/zh not_active Expired - Fee Related
- 1997-09-24 EP EP19970942194 patent/EP0962467A4/en not_active Withdrawn
- 1997-09-24 KR KR1020057025394A patent/KR100847441B1/ko not_active IP Right Cessation
- 1997-09-25 TW TW086113961A patent/TW509697B/zh not_active IP Right Cessation
-
1999
- 1999-03-25 NO NO991449A patent/NO991449L/no not_active Application Discontinuation
-
2005
- 2005-02-02 US US11/047,996 patent/US7358355B2/en not_active Expired - Fee Related
-
2007
- 2007-02-12 HK HK07101636.1A patent/HK1096974A1/xx not_active IP Right Cessation
- 2007-10-31 US US11/931,429 patent/US7842790B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
IL129164A (en) | 2007-05-15 |
TW509697B (en) | 2002-11-11 |
EP0962467A1 (en) | 1999-12-08 |
HUP9904177A2 (hu) | 2000-03-28 |
AU744146B2 (en) | 2002-02-14 |
US7842790B2 (en) | 2010-11-30 |
CZ106299A3 (cs) | 1999-08-11 |
CA2266332C (en) | 2012-01-03 |
US6903194B1 (en) | 2005-06-07 |
EP0962467A4 (en) | 2002-10-30 |
IL129164A0 (en) | 2000-02-17 |
US7358355B2 (en) | 2008-04-15 |
TR199900666T2 (xx) | 1999-06-21 |
WO1998013388A1 (fr) | 1998-04-02 |
HUP9904177A3 (en) | 2001-10-29 |
HK1096974A1 (en) | 2007-06-15 |
NO991449D0 (no) | 1999-03-25 |
AU4397297A (en) | 1998-04-17 |
SK40599A3 (en) | 2000-06-12 |
US20050136057A1 (en) | 2005-06-23 |
KR20060006981A (ko) | 2006-01-20 |
NO991449L (no) | 1999-05-25 |
RU2198220C2 (ru) | 2003-02-10 |
KR100847441B1 (ko) | 2008-07-21 |
CN100335501C (zh) | 2007-09-05 |
CN1237983A (zh) | 1999-12-08 |
US20080095772A1 (en) | 2008-04-24 |
CA2266332A1 (en) | 1998-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9713294A (pt) | "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano" | |
BR1100704KB1 (pt) | vetor recombinante, método para produzir um dna, método para produzir um polipeptìdeo, métodos que utilizam o referido polipeptìdeo, e cepa de escherichia coli. | |
BR9915548A (pt) | Proteìnas de fusão de interferon-beta e usos | |
EP0776331A4 (en) | HIGHER ORDER STRUCTURE AND BINDING OF PEPTIDE NUCLEIC ACIDS | |
BR0212256A (pt) | Proteìnas de fusão de transferrina modificadas | |
BR9713521A (pt) | ||
MX9304363A (es) | Metodo para enlace intracelular de moleculas blanco. | |
DK0994728T3 (da) | Rekombinante antistoffer, som er specifikke for beta-amyloide ender, DNA, der koder derfor, samt fremgangsmåder til anvendelse heraf | |
BR0314093A (pt) | Proteìnas de fusão de transferrina modificada-anticorpo | |
DK0759944T3 (da) | Forbedringer af og relateret til peptidfremføring | |
PT948541E (pt) | Analogos da pthrp | |
NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
BR9811094A (pt) | Agente terapêutico para tumores linfáticos | |
MXPA04001547A (es) | Proteina de leptina porcina, antisentido y anticuerpo. | |
AU4024097A (en) | Homocysteine desulphurase from the protozoan trichomonas vaginalis | |
DK0990703T3 (da) | Nyt polypeptid, DNA, som koder herfor, samt anvendelse heraf | |
BR9803296A (pt) | Moléculam anticorpo,uso de uma molécula, dna, vetor de dna recombinante, célula hospedeira,microorganismo, processo para produzir um anticorpo agente para o tratamento ou profilaxia de condições atribuìveis a normalidades do sistema ligando fas/fas, uso de uma molécula e hibridoma. | |
EP0972054A4 (en) | INCREASING IMMUNE RESPONSE USING TARGETED MOLECULES | |
ATE271125T1 (de) | Neuartige tyrosinkinase | |
EP1251176A3 (en) | Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide | |
ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
ES2164169T3 (es) | Proteinas estimulantes de celulas t de pestivirus. | |
DK0923644T3 (da) | G-koblet receptor, der udviser selektiv selektivitet for ATP | |
TR200002611T2 (tr) | Beta-lipotropin ve kullanımları | |
ATE332923T1 (de) | Cr1 fragmente und deren verwendung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI. |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |